Sibutramine Hydrochloride Hydrate

盐酸西布曲明水合物

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameSibutramine Hydrochloride Hydrate
Drug Alias Name西布曲明盐酸盐SibutraminumEctiva盐酸西布曲明单水合物Sibutramina +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsBinge-Eating DisorderWeight LossObesity
Global Approved IndicationsObesity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/11/22
Country/TerritoryUnited StatesUnited KingdomHong Kong +[4] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesChinese University Of Hong Kong (Cuhk)Glaxosmithkline Plc +[6] 
Active IndicationsN/A
Inactive IndicationsBinge-Eating DisorderWeight LossObesity

Other Information

ATC CodeA08AA10
Related LinksWikipediaDrugBankKEGG